{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:17:40Z","timestamp":1792264660463,"version":"4.4.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T00:00:00Z","timestamp":1489968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T00:00:00Z","timestamp":1489968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1038\/bmt.2017.15","type":"journal-article","created":{"date-parts":[[2017,3,20]],"date-time":"2017-03-20T15:20:02Z","timestamp":1490023202000},"page":"984-988","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Permanent diffuse alopecia after haematopoietic stem cell transplantation in childhood"],"prefix":"10.1038","volume":"52","author":[{"given":"D","family":"Bresters","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D C M","family":"Wanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Louwerens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L M","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Fiocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,20]]},"reference":[{"key":"BFbmt201715_CR1","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1182\/blood-2011-01-331835","volume":"118","author":"SH Armenian","year":"2011","unstructured":"Armenian SH, Sun CL, Kawashima T, Arora M, Leisenring W, Sklar CA et al. Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS). Blood 2011; 118: 1413\u20131420.","journal-title":"Blood"},{"key":"BFbmt201715_CR2","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.pcl.2009.11.008","volume":"57","author":"KS Baker","year":"2010","unstructured":"Baker KS, Bresters D, Sande JE . The burden of cure: long-term side effects following hematopoietic stem cell transplantation (HSCT) in children. Pediatr Clin North Am 2010; 57: 323\u2013342.","journal-title":"Pediatr Clin North Am"},{"key":"BFbmt201715_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/bmt.2009.92","volume":"45","author":"D Bresters","year":"2010","unstructured":"Bresters D, van Gils IC, Kollen WJ, Ball LM, Oostdijk W, van der Bom JG et al. High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study. Bone Marrow Transplant 2010; 45: 79\u201385.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201715_CR4","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.bbmt.2011.09.013","volume":"17","author":"ML Nieder","year":"2011","unstructured":"Nieder ML, McDonald GB, Kida A, Hingorani S, Armenian SH, Cooke KR et al. National Cancer Institute-National Heart, Lung and Blood Institute\/pediatric Blood and Marrow Transplant Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: long-term organ damage and dysfunction. Biol Blood Marrow Transplant 2011; 17: 1573\u20131584.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201715_CR5","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.bbmt.2013.04.002","volume":"19","author":"CL Sun","year":"2013","unstructured":"Sun CL, Kersey JH, Francisco L, Armenian SH, Baker KS, Weisdorf DJ et al. Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study. Biol Blood Marrow Transplant 2013; 19: 1073\u20131080.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201715_CR6","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/sj.bmt.1703695","volume":"30","author":"ME de Jonge","year":"2002","unstructured":"de Jonge ME, Mathot RA, Dalesio O, Huitema AD, Rodenhuis S, Beijnen JH . Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy. Bone Marrow Transplant 2002; 30: 593\u2013597.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201715_CR7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1007\/s11764-009-0091-4","volume":"3","author":"KE Kinahan","year":"2009","unstructured":"Kinahan KE, Gandhi M, Lacouture ME, Eilers R Jr, Haryani A, Didwania A et al. Dermatologic issues in adult survivors of childhood cancer. J Cancer Surviv 2009; 3: 158\u2013163.","journal-title":"J Cancer Surviv"},{"key":"BFbmt201715_CR8","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1200\/JCO.2011.39.3611","volume":"30","author":"KE Kinahan","year":"2012","unstructured":"Kinahan KE, Sharp LK, Seidel K, Leisenring W, Didwania A, Lacouture ME et al. Scarring, disfigurement, and quality of life in long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor study. J Clin Oncol 2012; 30: 2466\u20132474.","journal-title":"J Clin Oncol"},{"key":"BFbmt201715_CR9","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/DAD.0b013e3181fcfc25","volume":"33","author":"M Miteva","year":"2011","unstructured":"Miteva M, Misciali C, Fanti PA, Vincenzi C, Romanelli P, Tosti A . Permanent alopecia after systemic chemotherapy: a clinicopathological study of 10 cases. Am J Dermatopathol 2011; 33: 345\u2013350.","journal-title":"Am J Dermatopathol"},{"key":"BFbmt201715_CR10","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1002\/pbc.22992","volume":"57","author":"S Rogers","year":"2011","unstructured":"Rogers S, Donachie P, Sugden E, Sharpe G, English M, Robinson K et al. Comparison of permanent hair loss in children with standard risk PNETS of the posterior fossa following radiotherapy alone or chemotherapy and radiotherapy after surgical resection. Pediatr Blood Cancer 2011; 57: 1074\u20131076.","journal-title":"Pediatr Blood Cancer"},{"key":"BFbmt201715_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.jaad.2009.06.063","volume":"63","author":"B Tallon","year":"2010","unstructured":"Tallon B, Blanchard E, Goldberg LJ . Permanent chemotherapy-induced alopecia: case report and review of the literature. J Am Acad Dermatol 2010; 63: 333\u2013336.","journal-title":"J Am Acad Dermatol"},{"key":"BFbmt201715_CR12","first-page":"43","volume":"7","author":"BW Baker","year":"1991","unstructured":"Baker BW, Wilson CL, Davis AL, Spearing RL, Hart DN, Heaton DC et al. Busulphan\/cyclophosphamide conditioning for bone marrow transplantation may lead to failure of hair regrowth. Bone Marrow Transplant 1991; 7: 43\u201347.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201715_CR13","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/sj.bmt.1705817","volume":"40","author":"M Machado","year":"2007","unstructured":"Machado M, Moreb JS, Khan SA . Six cases of permanent alopecia after various conditioning regimens commonly used in hematopoietic stem cell transplantation. Bone Marrow Transplant 2007; 40: 979\u2013982.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201715_CR14","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1111\/j.1365-2133.2005.06469.x","volume":"152","author":"A Tosti","year":"2005","unstructured":"Tosti A, Piraccini BM, Vincenzi C, Misciali C . Permanent alopecia after busulfan chemotherapy. Br J Dermatol 2005; 152: 1056\u20131058.","journal-title":"Br J Dermatol"},{"key":"BFbmt201715_CR15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1046\/j.1440-0960.2000.00405.x","volume":"41","author":"D Tran","year":"2000","unstructured":"Tran D, Sinclair RD, Schwarer AP, Chow CW . Permanent alopecia following chemotherapy and bone marrow transplantation. Australas J Dermatol 2000; 41: 106\u2013108.","journal-title":"Australas J Dermatol"},{"key":"BFbmt201715_CR16","first-page":"869","volume":"15","author":"P Ljungman","year":"1995","unstructured":"Ljungman P, Hassan M, Bekassy AN, Ringden O, Oberg G . Busulfan concentration in relation to permanent alopecia in recipients of bone marrow transplants. Bone Marrow Transplant 1995; 15: 869\u2013871.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt201715_CR17","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood.V93.7.2196","volume":"93","author":"O Ringden","year":"1999","unstructured":"Ringden O, Remberger M, Ruutu T, Nikoskelainen J, Volin L, Vindelov L et al. Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group. Blood 1999; 93: 2196\u20132201.","journal-title":"Blood"},{"key":"BFbmt201715_CR18","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.jaad.2013.10.034","volume":"70","author":"M Choi","year":"2014","unstructured":"Choi M, Kim MS, Park SY, Park GH, Jo SJ, Cho KH et al. Clinical characteristics of chemotherapy-induced alopecia in childhood. J Am Acad Dermatol 2014; 70: 499\u2013505.","journal-title":"J Am Acad Dermatol"},{"key":"BFbmt201715_CR19","doi-asserted-by":"publisher","first-page":"e37","DOI":"10.1016\/j.jaad.2011.02.026","volume":"67","author":"SY Chon","year":"2012","unstructured":"Chon SY, Champion RW, Geddes ER, Rashid RM . Chemotherapy-induced alopecia. J Am Acad Dermatol 2012; 67: e37\u2013e47.","journal-title":"J Am Acad Dermatol"},{"key":"BFbmt201715_CR20","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1016\/S1470-2045(12)70553-3","volume":"14","author":"R Paus","year":"2013","unstructured":"Paus R, Haslam IS, Sharov AA, Botchkarev VA . Pathobiology of chemotherapy-induced hair loss. Lancet Oncol 2013; 14: e50\u2013e59.","journal-title":"Lancet Oncol"},{"key":"BFbmt201715_CR21","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.jaad.2010.03.020","volume":"64","author":"I Palamaras","year":"2011","unstructured":"Palamaras I, Misciali C, Vincenzi C, Robles WS, Tosti A . Permanent chemotherapy-induced alopecia: a review. J Am Acad Dermatol 2011; 64: 604\u2013606.","journal-title":"J Am Acad Dermatol"},{"key":"BFbmt201715_CR22","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1529-8019.2011.01430.x","volume":"24","author":"CE Yeager","year":"2011","unstructured":"Yeager CE, Olsen EA . Treatment of chemotherapy-induced alopecia. Dermatol Ther 2011; 24: 432\u2013442.","journal-title":"Dermatol Ther"},{"key":"BFbmt201715_CR23","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/ncb2059","volume":"12","author":"PA Sotiropoulou","year":"2010","unstructured":"Sotiropoulou PA, Candi A, Mascre G, De Clercq S, Youssef KK, Lapouge G et al. Bcl-2 and accelerated DNA repair mediates resistance of hair follicle bulge stem cells to DNA-damage-induced cell death. Nat Cell Biol 2010; 12: 572\u2013582.","journal-title":"Nat Cell Biol"},{"key":"BFbmt201715_CR24","doi-asserted-by":"publisher","first-page":"3569","DOI":"10.1182\/blood.V98.13.3569","volume":"98","author":"G Socie","year":"2001","unstructured":"Socie G, Clift RA, Blaise D, Devergie A, Ringden O, Martin PJ et al. Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies. Blood 2001; 98: 3569\u20133574.","journal-title":"Blood"},{"key":"BFbmt201715_CR25","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.bbmt.2010.09.022","volume":"17","author":"BS Andersson","year":"2011","unstructured":"Andersson BS, Valdez BC, de Lima M, Wang X, Thall PF, Worth LL et al. Clofarabine +\/- fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS. Biol Blood Marrow Transplant 2011; 17: 893\u2013900.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt201715_CR26","first-page":"147","volume":"81","author":"GA Severs","year":"2008","unstructured":"Severs GA, Griffin T, Werner-Wasik M . Cicatricial alopecia secondary to radiation therapy: case report and review of the literature. Cutis 2008; 81: 147\u2013153.","journal-title":"Cutis"},{"key":"BFbmt201715_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1001\/jamadermatol.2014.1550","volume":"151","author":"RC Zuo","year":"2015","unstructured":"Zuo RC, Naik HB, Steinberg SM, Baird K, Mitchell SA, Kuzmina Z et al. Risk factors and characterization of vitiligo and alopecia areata in patients with chronic graft-vs-host disease. JAMA Dermatol 2015; 151: 23\u201332.","journal-title":"JAMA Dermatol"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt201715.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201715","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/bmt.2017.15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/www.nature.com\/articles\/bmt201715.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T19:16:04Z","timestamp":1648062964000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt201715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,20]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["BFbmt201715"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2017.15","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,20]]},"assertion":[{"value":"28 September 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2017","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}